DALE CONOVER: Open Payments
NPI 1568904852 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 37 payments from 8 companies in 2025. Trend: 2023 $560 · 2024 $582 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $158 |
| Novo Nordisk Inc | 5 | $133 |
| Exact Sciences Corporation | 5 | $81 |
| Acella Pharmaceuticals, LLC | 3 | $69 |
| Corcept Therapeutics | 3 | $65 |
| ABBVIE INC. | 2 | $62 |
| Amgen Inc. | 4 | $61 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: MOUNJARO, Rybelsus, The Cologuard Plus Collection Kit, NP Thyroid 60, Korlym, UBRELVY, REPATHA, Ozempic.
Industry payments across TX — which companies pay providers there.
